US SEC Filings Daily Market Digest — September 25, 2026

25-09-2026

VerifyMe, Inc. held its Annual Meeting of Stockholders on September 24, 2026, with approximately 6,168,364 shares (46.34% of outstanding shares) present or represented by proxy. Stockholders approved the merger with OpenWorld, the advisory compensation of named executive officers, the Fourth Amendment to the 2020 Equity Incentive Plan, and ratified MaloneBailey, LLP as the independent auditor. However, stockholders did not approve the proposal to authorize 500,000,000 shares of new 'blockchain common stock' and related charter amendments, including the name change to 'OpenWorld, Inc.'

• · The merger with OpenWorld was approved, with OpenWorld surviving as a wholly owned subsidiary of VerifyMe.
• · The proposal to authorize 500,000,000 shares of blockchain common stock (par value $0.001 per share) was not approved by stockholders.
• · The company's name change to 'OpenWorld, Inc.' was part of the rejected proposal.
• · The adjournment proposal was approved with 5,703,929 votes for, 454,654 against, and 9,781 abstentions.
• · The company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.

25-09-2026

BOXABL Inc. (Nasdaq: BXBL) appointed Timothy Goldsmith, CPA, a former EY audit partner with over 20 years of experience, to its board of directors as Audit Committee Chair, effective September 24, 2026. The appointment follows the recent additions of CFO Larry King and CAO Heather Clayton, as the company builds out its finance and governance infrastructure after going public in July 2026. The filing is a routine governance update with no negative or flat financial metrics reported.

• · Timothy Goldsmith spent nearly 21 years at EY, most recently as an audit partner from 2018 to 2026.
• · Goldsmith oversaw more than 20 complex public and private company audits and led a team of over 30 audit executives.
• · He led audit strategy for companies with revenues ranging from $200 million to over $3 billion.
• · Goldsmith holds a BBA in Accounting and Business Economics from Ohio University and is a CPA licensed in Ohio, Georgia, New Jersey, and Nevada.
• · Dr. Morris A. Davis, who previously chaired the Audit Committee, will remain a member of the committee.
• · BOXABL began trading on Nasdaq under ticker 'BXBL' on July 20, 2026, following its business combination with FG Merger II Corp.
• · The company has raised over $230 million from more than 50,000 investors since its inception in 2017.

25-09-2026

C4 Therapeutics presented new biomarker data from its Phase 1 trial of cemsidomide with dexamethasone and the Phase 1b trial with elranatamab (ELREXFIO) in relapsed/refractory multiple myeloma at the 2026 IMS Annual Meeting. The Phase 1 data in 62 heavily pre-treated patients showed coordinated T-cell activation and NK-cell reprogramming, with enhanced immune function at the highest dose levels (75 µg and 100 µg) that also achieved compelling overall response rates. The Phase 1b trial is advancing into a 100 µg dose escalation cohort and a 75 µg expansion cohort, with data from all cohorts expected in mid-2027.

• · The safety data review committee declared the 75 µg cemsidomide dose level in combination with elranatamab safe after the first safety cohort of six patients.
• · Biomarker data from the first two Phase 1b patients showed cemsidomide drives expansion and activation of CD8+ effector memory T cells (elevated HLA-DR) and prevents T-cell exhaustion (PD-1, TIM-3, LAG3 expression).
• · Data from all cohorts in the Phase 1b trial are expected in mid-2027.

25-09-2026

Quantum Cyber N.V. (formerly Mainz Biomed N.V.) announced a sharpened strategic focus on three product pillars: quantum antenna technology, one-way attack/interceptor drones, and the MAHCA operating system, anchored at its Bridgeport, Connecticut manufacturing facility. The company de-emphasized maritime programs and other exploratory initiatives to concentrate resources on near-term commercialization. No financial results or period-over-period comparisons were provided in this filing.

• · Company changed name from Mainz Biomed N.V. to Quantum Cyber N.V. on November 12, 2021.
• · Exclusive intellectual property license agreement with Project LightShift, Inc. executed on June 11, 2026.
• · Bridgeport facility acquired on July 16, 2026; 80-unit 3D printing drone production farm became operational on August 31, 2026.
• · Executive Order 14307 establishes American drone dominance as a national security priority.
• · Company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.
• · Maritime programs and other exploratory initiatives have been de-emphasized.

25-09-2026

Hotel101 Global Holdings Corp. announced a bulk sale of 780 units to a third-party consortium for an expected total contract price of approximately US$205 million, with an additional 300 units to be purchased from an affiliate for US$33 million. The consortium also placed deposits for 300 units at two development projects. The transaction was approved by the Audit Committee and Board, and the controlling shareholder DoubleDragon Corporation is a minority investor. The company frames this as a strategic step to strengthen its PropTech platform and support its global expansion, though forward-looking statements highlight significant risks.

• · Revenue from the sale is expected to be recognized on a percentage-of-completion basis.
• · The consortium has placed a deposit for 300 units at Hotel101-Melbourne (Australia) and Hotel101-Milan (Italy), both under development.
• · DoubleDragon Corporation's Board approved the creation of a Singapore SPV, DD Hotel101 Worldwide One, which may be sponsored and listed as a REIT.
• · The transaction was reviewed and approved by the Company's Audit Committee and Board of Directors.
• · Forward-looking statements include risks related to project completion, land rights, regulatory inquiries, and potential construction defects.

25-09-2026

CAO SPECTER ERIC M was awarded 672 Common Stock. SPECTER ERIC M holds 36,154 shares after the transaction.

• · CAO SPECTER ERIC M was awarded 672 Common Stock

25-09-2026

Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.

25-09-2026

Director Dean Robert Alan was awarded 907 Deferred Share Units at $23.42 (~$21.2K).

• · Director Dean Robert Alan was awarded 907 Deferred Share Units at $23.42 (~$21.2K)

25-09-2026

Elroy Air, a developer of autonomous heavy-cargo drones, announced an upsizing of its PIPE investments to $175 million in connection with its proposed business combination with Inflection Point Acquisition Corp. VII (IPAC). Lockheed Martin Ventures and existing investors participated, with $75 million already funded prior to closing. The company also highlighted recent milestones including a $46 million U.S. Army contract, expanded early delivery reservations from Bristow Group (15 total), and the first autonomous flights under the FAA's eIPP program.

• · Elroy Air has been awarded a multi-year contract worth up to $46 million with the U.S. Army, building on previous contracts from the past two years.
• · Elroy Air completed the first autonomous and uncrewed flights authorized under the FAA's eIPP program, in partnership with LIFTOFF Louisiana and Bristow Group.
• · Bristow Group expanded its early delivery reservations for Chaparral by 10 additional positions, for a total of 15, and has a pre-order agreement for up to 100 Chaparral drones.
• · Kratos Defense & Security Solutions is the exclusive U.S. manufacturer of Chaparral, with first production aircraft planned for late 2026 at its Sacramento, California facility.
• · The Chaparral drone has a cargo capacity of 500+ pounds, a range of up to 450 miles, and a hybrid-electric powertrain requiring no charging infrastructure.

25-09-2026

Tamboran Resources Corp reported first gas sales to the Northern Territory gas market in September 2026, a key milestone. The company completed the largest stimulation campaign in the Beetaloo Basin (178 stages) and delivered the SPCF construction ~US$9 million under budget. However, the pro forma cash balance of ~US$240 million is down from the US$300 million raised earlier, and the company carries US$30 million in debt, with near-term inflows of only US$15 million pending conditions.

• · Tamboran is the fourth largest listed-Australian E&P by market capitalization (A$1,928 million).
• · Implied acreage value is US$377 per acre.
• · The company has 3-4 stacked benches across two key depocenters.
• · First gas sales commenced in September 2026 under interruptible supply terms at 75% of gas price.
• · Take-or-pay provisions will apply to the 40 TJ/d contract quantity upon commencement of the supply period.
• · A non-binding MOU with Liberty Energy sets out intent to extend the hydraulic fracture stimulation and wireline services agreement.
• · The acreage sale to DWE (US$15 million) is subject to conditions precedent including DWE obtaining approval from the Formentera Australia Fund, LP’s Limited Partner Advisory Committee.
• · Working interests are subject to completion of minority shareholder compulsory acquisition of Falcon Oil & Gas Australia Limited.

25-09-2026

Blue Acquisition Corp. filed an 8-K on September 25, 2026, disclosing an updated investor presentation related to its proposed business combination with Blockfusion USA, Inc. The transaction, governed by a Business Combination Agreement (BCA) first signed on November 19, 2025, has been amended six times, with the latest amendment on September 21, 2026. The filing does not provide any financial figures or performance metrics, only procedural and forward-looking statements.

• · The BCA has been amended six times since November 19, 2025, with the most recent amendment on September 21, 2026.
• · The updated investor presentation supersedes an earlier version previously furnished with the SEC.
• · The filing is made under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).
• · The transaction involves Blue and Blockfusion becoming wholly-owned subsidiaries of Pubco, which will become a publicly traded company.
• · No financial data, redemption levels, or specific closing conditions are disclosed in this filing.

25-09-2026

VP - CAO & Corp Controller Peck Laurene E was awarded 2,192 Common Stock at $83.94 (~$184K). Peck Laurene E holds 9,160 shares after the transaction.

• · VP - CAO & Corp Controller Peck Laurene E was awarded 2,192 Common Stock at $83.94 (~$184K)

25-09-2026

Director MARTINEZ ANGEL R was awarded 2,780 Common Stock, par value $0.01 per share. MARTINEZ ANGEL R holds 31,040 shares after the transaction.

• · Director MARTINEZ ANGEL R was awarded 2,780 Common Stock, par value $0.01 per share

25-09-2026

Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.

25-09-2026

Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.

25-09-2026

Director Oei Khing Djien sold 168,750 Common Stock at $3.92 (~$662K).

• · Director Oei Khing Djien sold 168,750 Common Stock at $3.92 (~$662K)

25-09-2026

AJB Investment Fund II, LP and affiliated persons disclosed in an amended Schedule 13D that they collectively beneficially own 509,069 shares of Jewett Cameron Trading Co Ltd, representing approximately 14.46% of outstanding shares as of September 25, 2026. The filing indicates the group believes the shares were undervalued and may engage with management and the board on corporate governance, strategy, and other matters to increase shareholder value. However, the reporting persons state they currently have no specific plans for any of the actions itemized in Item 4 of Schedule 13D, and may increase or decrease their position depending on market conditions.

• · The filing was made on September 25, 2026 as an amendment (Schedule 13D/A).
• · The group bought shares in multiple open-market transactions between August 24, 2026 and September 25, 2026, with prices ranging from $2.09 to $2.93 per share.
• · The largest single purchase was 10,000 shares on September 15, 2026 at $2.89.
• · The reporting persons reserve the right to engage in hedging, short selling, or derivative transactions with respect to the shares.

25-09-2026

Paramount Skydance Corp (PSKY) announced it will voluntarily transfer its stock listing from Nasdaq to the NYSE effective October 6, 2026, and set a record date of October 5, 2026 for a distribution of warrants to purchase Class B common stock. The warrant distribution—expected to be approximately 470 million warrants—is contingent on the closing of the pending Warner Bros. Discovery merger, which remains uncertain with no assurance on timing or completion. The warrants will have an exercise price between $12.00 and $16.02 per share, expire 10 years after issuance, and may be redeemed early if the stock price hits $30.00 for 20 out of 30 consecutive trading days after the third anniversary, while certain holders and plans are excluded or receive shares instead.

• · The warrant distribution excludes Restricted Holders (Lawrence J. Ellison, David F. Ellison, Gerald J. Cardinale, the Lawrence J. Ellison Revocable Trust, and RedBird Capital Partners Fund IV) and their affiliates, as well as the Paramount Global 401(k) Plan and Paramount Global Master Trust (which will receive shares instead of warrants).
• · The warrants will trade separately on the NYSE if approved.
• · The Company may cancel or postpone the record date and/or issue date at its discretion if the WBD Merger does not close as expected.

25-09-2026

Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.

25-09-2026

Director Oliver George was awarded 1,802 Ordinary Shares. Oliver George holds 1,802 shares after the transaction.

• · Director Oliver George was awarded 1,802 Ordinary Shares

25-09-2026

EVP, Corporate Operations Nettie Norman V was awarded 176,056 Common Stock. Nettie Norman V holds 529,781 shares after the transaction.

• · EVP, Corporate Operations Nettie Norman V was awarded 176,056 Common Stock

25-09-2026

Titan International (TWI) announced a definitive agreement to sell its ITM undercarriage business to USCO S.p.A. for up to approximately $285 million in total cash value, including a $207 million initial purchase price, a $6 million earnout, and an expected $23 million in closing adjustments. The transaction is expected to close in early January 2027, subject to regulatory approvals. Proceeds will be used to reduce debt and fund growth investments, though the deal is subject to customary closing conditions and risks.

• · Transaction expected to close early January 2027, subject to regulatory approvals and customary conditions
• · Titan intends to use proceeds to reduce debt and fund growth investments, including accretive acquisitions and partnerships
• · ITM serves construction, mining, forestry, road-building, agricultural applications globally
• · Titan has bought back over $100 million of its common stock in recent years
• · ITM's Cecilia La Manna will continue to lead the business under USCO
• · Exchange rate used: €1.00 = $1.148 as of September 18, 2026

25-09-2026

Central Puerto S.A. disclosed a share buyback transaction on the BYMA exchange, purchasing 100,000 shares at an average price of ARS 2,007.63 per share for a total cash amount of ARS 200,763,464. The transaction was executed on September 25, 2026, with trade completion on September 28, 2026. No NYSE transactions were reported for this period.

• · Transaction date: September 25, 2026
• · Trade completion date: September 28, 2026
• · Average price per share: ARS 2,007.63
• · No share repurchase activity on NYSE for this period

25-09-2026

Director Milligan Sandra was awarded 10,000 Stock Option (Right to Buy).

• · Director Milligan Sandra was awarded 10,000 Stock Option (Right to Buy)

25-09-2026

Chief Financial Officer Smith Debra Lou reported beneficial ownership in CISO Global, Inc.. This amends a previously filed Form 4. 1 position reported.

• · Holds 0 Common Stock (direct)

25-09-2026

Warner Bros. Discovery, Inc. (WBD) filed an amendment to its Schedule 13G, disclosing beneficial ownership of 11,720 Class A Ordinary Shares of VS MEDIA Holdings Ltd, representing 0.4% of the 2,750,784 Class A Ordinary Shares outstanding as of August 21, 2026. The shares are held directly by WBD's indirect wholly-owned subsidiary, Discovery Networks Asia-Pacific Pte. Ltd., with WBD deemed to share voting and investment power. The filing reflects a minor passive stake, with no change in ownership percentage from the prior filing.

• · The filing is an amendment (SC 13G/A) filed on September 25, 2026, under Rule 13d-1(d).
• · Discovery Networks Asia-Pacific Pte. Ltd. is an indirect wholly-owned subsidiary of Warner Bros. Discovery, Inc.
• · The ownership percentage is based on 2,750,784 Class A Ordinary Shares outstanding as of August 21, 2026, as reported in the Issuer's Amendment No. 2 to Form F-3.
• · The shares are held directly by Discovery Networks Asia-Pacific Pte. Ltd., with WBD deemed to share voting and investment power over these shares.
• · No change in ownership percentage (0.4%) from the prior filing, indicating a flat position.

25-09-2026

Nextdoor Holdings, Inc. announced that Craig Lisowski will resign as President of Products, effective October 16, 2026. The resignation is not due to any disagreement with the company's operations, policies, or practices. No replacement or interim appointment has been disclosed.

• · Resignation effective date: October 16, 2026
• · Resignation date: September 21, 2026
• · No disagreement cited as reason for departure
• · No successor named in the filing

25-09-2026

NextCure filed a Section 205 petition in the Delaware Court of Chancery seeking validation of its July 2025 reverse stock split (1:12) and all shares issued in reliance on it, following uncertainty created by August 2026 amendments to Delaware law. The court has scheduled a hearing for November 6, 2026, and the company is also pursuing a proposed business combination with Avere Therapeutics. While the reverse split received overwhelming stockholder support (89.92% of votes cast), the outcome of the Section 205 action is uncertain and could delay or prevent the Avere transaction if unsuccessful.

• · The 2025 Reverse Split Amendment was approved by the board at a 1:12 ratio and filed with the Delaware Secretary of State on July 10, 2025.
• · The Section 205 Action is captioned In re NextCure, Inc., C.A. No. 2026-1203-JTL.
• · The hearing is scheduled for 3:00 p.m. (Eastern Time) on November 6, 2026, at the Leonard L. Williams Justice Center, 500 North King Street, Wilmington, Delaware 19801.
• · Stockholders may file written submissions with the Register in Chancery by October 27, 2026.
• · The company's definitive proxy statement for the 2025 Annual Meeting applied a 'votes cast' standard based on its interpretation of Section 242(d)(2) of the DGCL as then in effect.
• · No stockholder has previously challenged the voting standard disclosure or the validity of the 2025 Reverse Split.
• · The company intends to file a Form S-4 with the SEC in connection with the proposed Avere transaction.

25-09-2026

Monster Beverage Corporation announced that CEO Americas Rob Gehring will resign effective November 30, 2026, to return to The Coca-Cola Company as president of its North America operating unit. Emelie C. Tirre, Chief Strategy Officer, will assume interim responsibility for the Americas and Caribbean starting December 1, 2026. The departure is a key leadership change but does not involve financial results or regulatory action.

• · Rob Gehring's resignation is effective November 30, 2026.
• · Emelie C. Tirre, age 57, previously served as Chief Commercial Officer of the Americas, the Caribbean and Oceania through February 24, 2026.
• · Ms. Tirre's biographical information is incorporated by reference from the March 27, 2026 proxy statement.

25-09-2026

The Scotts Miracle-Gro Company filed an amendment to its Form 8-K to correct a typographical error regarding the departure of director Adam Hanft. The original filing stated Mr. Hanft had retired from the Board, but the amendment clarifies that he resigned effective September 8, 2026. The company's consulting relationship with Hanft Ideas LLC, where Mr. Hanft is principal and CEO, will continue after his resignation.

• · Mr. Hanft was a Class III director whose term was set to expire at the 2028 Annual Meeting of Shareholders.
• · The consulting relationship with Hanft Ideas LLC will continue following the resignation.

25-09-2026

Circle Internet Group, Inc. (NYSE: CRCL) announced that CFO Jeremy Fox-Geen intends to step down after more than five years, effective end of December 2026 or upon appointment of a successor. The company has commenced a search with a leading executive search firm. Fox-Geen played key roles in building the financial organization, navigating a $1.2 billion IPO, and contributing to over five years of strong growth.

• · Jeremy Fox-Geen joined Circle in May 2021.
• · He will continue as CFO through end of December 2026 unless a successor is appointed sooner.
• · The company has engaged a leading executive search firm for the CFO search.
• · Fox-Geen's departure is described as a step down to take a break before his next chapter.

25-09-2026

Ocean Power Technologies (OPTT) provided an update on its defense and security market activities, highlighting participation in the NATO REPMUS 2026 exercise with the U.S. Navy and Marine Corps, and an official evaluation with the U.S. Army Corps of Engineers. The company reported a backlog of $20 million and a qualified pipeline of over $150 million, with a focus on converting backlog to revenue by the end of its fiscal year (April 30, 2027). However, the filing is a transcript of an interview and does not include any financial results or period-over-period comparisons, so no negative or flat metrics are available.

• · The company integrated three classes of uncrewed surface vehicles into the Navy's common control software during REPMUS.
• · Vehicles executed mine countermeasures, ISR, surveillance, and security missions.
• · The Army Corps evaluation included three days of operations in surf zone conditions off Duck, North Carolina.
• · The company's fiscal year ends April 30, 2027.
• · Earlier in the year, OPTT placed four PowerBuoys with the Coast Guard under a DHS contract.

25-09-2026

Golub Capital Private Income Fund S disclosed the unregistered sale of 81,237 common shares at $24.25 NAV per share for total consideration of $1,970,000 as of September 1, 2026. The fund also declared a September 2026 net distribution of $0.1498 per share, payable to shareholders of record on September 30, 2026. As of August 31, 2026, the fund's portfolio had a total fair value of approximately $249 million across 171 companies, with 98% in first lien senior secured debt and a net asset value of approximately $121 million.

• · The fund's debt-to-equity leverage ratio was 1.17x and GAAP debt-to-equity ratio, net of cash, was 1.13x as of August 31, 2026.
• · The top industry exposure was Software at 25% of fair value, followed by Insurance (10%) and Healthcare Providers & Services (7%).
• · Three debt investments representing less than 1% of the portfolio had a fixed interest rate.
• · No underwriting discounts or commissions were paid in connection with the share sale; however, investors purchasing through certain intermediaries may be charged fees up to 3.5% of NAV.

25-09-2026

Golub Capital Private Income Fund I reported unregistered sales of 96,269 common shares at $24.30 per share, raising approximately $2.34 million, and declared a September 2026 distribution of $0.1667 per share. As of August 31, 2026, the fund had a portfolio of 171 companies with a fair value of about $438 million, an aggregate NAV of approximately $212 million, and a debt-to-equity leverage ratio of 1.14x. The portfolio is heavily weighted toward first lien senior secured debt (99%) and floating-rate investments (100% of debt), with a top industry concentration in software at 25%.

• · NAV per common share as of August 31, 2026 was $24.30.
• · The September 2026 distribution of $0.1667 per share is payable to shareholders of record as of September 30, 2026, with payment on or around October 30, 2026.
• · The fund's GAAP debt-to-equity ratio, net of cash and foreign currencies, was 1.11x.
• · Three debt investments representing less than 1% of the portfolio had fixed interest rates.
• · The ten largest industries include Insurance (9%), Commercial Services & Supplies (8%), Healthcare Providers & Services (6%), Hotels, Restaurants & Leisure (5%), Healthcare Equipment & Supplies (5%), Automobiles (4%), Healthcare Technology (4%), Professional Services (4%), and Containers & Packaging (4%).

25-09-2026

Quality Industrial Corp. (QIND) entered into a Share Exchange Agreement with its majority owner Fusion Fuel Green PLC on September 23, 2026, under which Fusion Fuel will issue 500,000 Class A ordinary shares valued at $2,000,000 to three third-party investors in exchange for QIND issuing $2,000,000 of its common stock to Fusion Fuel. Concurrently, QIND amended its existing Share Purchase Agreement for its 51% stake in Al Shola Gas, restructuring the $10,000,000 purchase price with $2,000,000 satisfied by the share exchange, $6,000,000 due by December 31, 2027, and $980,000 in cash by the same date. The transactions are subject to Nasdaq listing approval and other conditions, and the amendment eliminates prior debt financing obligations while granting QIND a call option to acquire the remaining 49% of Al Shola Gas at a pro rata valuation of $10,000,000.

• · The Share Exchange Agreement includes a mutual waiver and release of certain claims and mutual indemnification obligations capped at $2,000,000 with a $50,000 deductible.
• · The Agreement and Amendment No. 2 eliminates all previously existing obligations of QIND to provide or arrange debt financing, credit facilities, equity lines, or bank guarantees for Al Shola Gas or the Investors.
• · QIND has an irrevocable call option, exercisable until March 27, 2027, to purchase all or any portion of the remaining Al Shola Gas shares held by Investors at $65,359.48 per share.
• · Non-competition and non-solicitation restrictions on Investors are extended from 2 years to 4 years under the amendment.
• · The Share Exchange Agreement is governed by New York law with binding arbitration in New York before a panel of three arbitrators.
• · If the Parent Shares are not issued by December 31, 2026, QIND must make an Alternative Payment in cash or listed securities within 10 calendar days.

25-09-2026

Stitch Fix, Inc. announced that board member J. William Gurley will not stand for re-election at the 2026 Annual Meeting and will retire upon expiration of his current term. The departure is not due to any disagreement with the company. No financial metrics or performance data were disclosed in this filing.

• · Mr. Gurley's decision is not the result of any disagreement with the company on operations, policies, or practices.
• · The retirement will take effect at the 2026 Annual Meeting of Stockholders.

25-09-2026

Pulmatrix, Inc. is proposing a merger with Eos SENOLYTIX Inc. via a reverse merger structure where Merger Sub (a Pulmatrix subsidiary) will merge into Eos, making Eos a wholly owned subsidiary of Pulmatrix. The combined company will prioritize Eos's preclinical geropeptide pipeline targeting aging-related conditions, while continuing Pulmatrix's iSPERSE™ dry powder delivery platform as a business stream. Pulmatrix stockholders will receive approximately 6% ownership in the combined entity. The merger is motivated by Pulmatrix's inability to secure funding for its own pipeline and a decline in biotech financing, while Eos seeks public market access. The proxy also includes a reverse stock split proposal. No specific financial figures are disclosed in this excerpt.

• · Pulmatrix's PUR3100 received FDA IND acceptance for a Phase 2 study and a direct-to-Phase 3 pathway is being explored; Pulmatrix is seeking a licensing partner for this product.
• · Pulmatrix's partner Cipla has been approved to commence a Phase 3 trial in India for PUR1900; Pulmatrix will receive 2% royalties on net sales outside the U.S. and shares 50%/50% on U.S. development.
• · PUR1800 has completed Phase 1 but is dependent on a third-party license.
• · Eos is in preclinical stage with IND-enabling studies for PTC-2105; no clinical trials have started.
• · The merger is structured as a tax-free reorganization under Section 368(a) of the Internal Revenue Code for Eos stockholders; Pulmatrix stockholders will not recognize gain or loss on the reverse stock split except for cash in lieu of fractional shares.
• · Pulmatrix directors and officers have interests in the merger including continued indemnification and insurance, and outstanding warrants will survive the closing.

25-09-2026

Akamai Technologies announced that its Audit Committee adopted amendments to the Company's Code of Ethics on September 22, 2026, effective for all employees, directors, officers, executives, and contractors. The amendments enhance clarity, organization, and scope, including new defined terms, roles and responsibilities, and expanded coverage of emerging focus areas. No waivers were granted, and no financial or operational metrics were affected.

• · The amendments were adopted by the Audit Committee on September 22, 2026, and the 8-K was filed on September 25, 2026.
• · The Code applies to all employees, directors, officers, executives, and contractors.
• · The amendments did not result in any waiver of the prior Code provisions.
• · The updated Code is available on the company's website at www.ir.akamai.com/corporate-governance/highlights.

25-09-2026

Coty Inc. filed a revised definitive proxy statement (DEFR14A) on September 25, 2026, to correct the proxy card for Proposal 5 (frequency of say-on-pay vote) to align with SEC Rule 14a-4. The filing details the 2026 Annual Meeting scheduled for November 5, 2026, and highlights a challenging fiscal 2026 with pressure on sales, gross margin, and profitability, while noting strategic actions including the monetization of the remaining Wella stake (contributing to a nearly $840 million year-over-year net debt reduction), a $400 million cash proceeds agreement with Kering for early transition of the Gucci Beauty license, and a significant board refreshment with five new independent directors.

• · Annual Meeting to be held virtually on November 5, 2026, at 8:30 a.m. ET.
• · Record date for voting is September 10, 2026.
• · Proposals include election of nine directors, approval of amended equity and long-term incentive plan, approval of amended stock plan for directors, advisory say-on-pay vote, advisory vote on frequency of say-on-pay, and ratification of Deloitte & Touche LLP as auditor.
• · Fiscal 2026 was described as a challenging year with pressure on sales, gross margin, and profitability.
• · In September 2025, Coty announced a strategic review of its consumer beauty business, including mass color cosmetics and Brazil business.
• · In December 2025, Coty completed monetization of remaining Wella stake, contributing to a nearly $840 million year-over-year reduction in net debt.
• · In March 2026, Coty announced the Coty.Curated framework.
• · In early July 2026, Coty reached an agreement with Kering for early transition of Gucci Beauty license, securing $400 million in cash proceeds plus inventory proceeds.
• · Board refreshment: five new independent directors appointed in March 2026, and Patricia Capel, Joachim Creus, and Frank Engelen appointed in January 2026.
• · Fiscal 2027 expected to be a transition year as strategic review completes and Coty.Curated implementation advances.

25-09-2026

Lifeward Ltd. filed a DEF 14A proxy statement for its 2026 Annual General Meeting, seeking shareholder approval for the re-election of Class III directors Haggai Zamir and Avraham Gabay. The filing details significant corporate events, including the March 2026 acquisition of Oratech Pharma, Inc. from Oramed, which resulted in the issuance of 2,256,476 ordinary shares and pre-funded warrants, representing 45.0% of outstanding shares post-closing, and subsequent board changes. The proxy also notes a sharp decline in the company's stock price from $14.76 on June 4, 2025 to $7.60 on August 15, 2025, reflecting a 48.5% drop.

• · The proxy statement is first being mailed on or about October 7, 2026.
• · Shareholders may submit position statements on agenda items by October 20, 2026.
• · The board was increased from five to eight seats in connection with the Oratech Acquisition.
• · Quarterly revenue sharing payments based on sales of ReWalk Personal Exoskeleton products and related extended warranties are part of the consideration to Oramed.
• · The stock price dropped from $14.70 on June 2, 2025 to $8.60 on August 13, 2025, a 41.5% decline, before further falling to $7.60 on August 15, 2025.